Suchergebnisse - "Marinello, Arianna"

PubPharm (14)

1

Response to first-line pembrolizumab in metastatic KRAS-mutated non-small-cell lung cancer

enthalten in: Future oncology (London, England) | 2024

von Rossi, S. | Pagliaro, A. | Finocchiaro, G. | +8

2

Prevalence of Thromboembolic Events in Patients With Non-Small Cell Lung Cancer and RET Fusions

enthalten in: JAMA oncology | 2023

von Aldea, M. | Marinello, A. | Guyon, D. | +4

3

RET-MAP : An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Aldea, M. | Marinello, A. | Duruisseaux, M. | +42

CommentIn: J Thorac Oncol. 2023 May;18(5):549-551. - PMID 37087114

4

Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors

enthalten in: JCO precision oncology | 2023

von Aldea, M. | Tagliamento, M. | Bayle, A. | +30

5

Current treatment approaches for brain metastases in ALK/ROS1/NTRK-positive non-small-cell lung cancer

enthalten in: Expert review of anticancer therapy | 2023

von Rossi, S. | Marinello, A. | Pagliaro, A. | +6

6

KRAS in NSCLC : State of the Art and Future Perspectives

enthalten in: Cancers | 2022

von Cascetta, P. | Marinello, A. | Lazzari, C. | +5

7

A Case of Pulmonary Sarcoidosis during First-Line Targeted Therapy with Dabrafenib Plus Trametinib in BRAF V600E-Mutated Metastatic Melanoma

enthalten in: Case reports in oncology | 2022

von Tronconi, M. | Marinello, A. | Solferino, A. | +7

8

Uncommon single and compound EGFR mutations : clinical outcomes of a heterogeneous subgroup of NSCLC

enthalten in: Current problems in cancer | 2022

von Rossi, S. | Damiano, P. | Toschi, L. | +6

9

Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non-Small-Cell Lung Cancer

enthalten in: Clinical lung cancer | 2021

von Gregorc, V. | Mazzarella, L. | Lazzari, C. | +23

10

Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab

enthalten in: Breast (Edinburgh, Scotland) | 2021

von De Sanctis, R. | Giordano, L. | D'Antonio, F. | +8